1-2 of 2
Jessica Altman, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Selective Anti Leukemic Effect of BL-8040, a Peptidic CXCR4 Antagonist, Is Mediated By Induction of Leukemic Blast Mobilization, Differentiation and Apoptosis: Results of Correlative Studies from a Ph2a Trial in Acute Myeloid Leukemia

Gautam Borthakur, MD, Martin S. Tallman, MD, Yishai Ofran, MD, James M. Foran, MD, Geoffrey L Uy, MD, John F DiPersio, MD PhD, Arnon Nagler, Jacob M. Rowe, MD, Margaret M. Showel, MD, Jessica Altman, MD, Ahmed Al-Rawi, Rui-Yu Wang, MD PhD, Amnon Peled, PhD, Michal Abraham, PhD, Yaron Pereg, PhD, Abi Vainstein, MD, Galia Oberkovitz, PhD, Tzipi Lustig, DVM, Arnon Aharon, MD, Carlos E. Bueso-Ramos, MD PhD, Jorge E. Cortes, MD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2745.
https://doi.org/10.1182/blood.V128.22.2745.2745
Published: 2016
Journal Articles

A Randomized Phase 2 Study of Sapacitabine, An Oral Nucleoside Analogue, in Older Patients with Myelodysplastic Syndrome (MDS) Refractory to Hypomethylating Agents.

Guillermo Garcia-Manero, MD, Selina Luger, MD, Parameswaran Venugopal, MD, Lori J. Maness, MD, Meir Wetzler, MD, Jessica Altman, MD, David F. Claxton, M.D., Stephen Strickland, MD, Stefan Faderl, MD, Judy Chiao, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2009) 114 (22): 1758.
https://doi.org/10.1182/blood.V114.22.1758.1758
Published: 2009